Skip to main content
. 2022 Jul 22;10:53–58. doi: 10.1016/j.sopen.2022.07.003

Table 2.

Tumor characteristics and laboratory values

Age < 70 (n = 1056) Age 70 + (n = 477) P value
Tumor size, mean (SD), cm 5.6 (4.4) 6.2 (4.3) P < .001
Bilateral, no. (%) 134 (14.7) 57 (13.3) P = .51
Single tumor, no. (%) 690 (67.2) 350 (73.8) P = .009
Met Milan criteria, no. (%) 462 (43.8) 178 (37.4) P = .02
Normal AFP, no. (%) 414 (39.4) 212 (45.0) P = .04
AFP, mean (SD), ng/mL 11,980 (54576) 9743 (60365) P = .006
Cirrhosis, no. (%) 774 (74.4) 303 (64.6) P < .001
Rupture, no. (%) 40 (3.8) 18 (3.8) P = .99
APRI, mean (SD) 0.79 (0.84) 0.45 (0.64) P < .001
MELD, mean (SD) 10.5 (4.5) 10.2 (4.09) P = .56
Childs–Turcotte–Pugh Score, mean (SD) 6.5 (2.0) 5.9 (1.4) P < .001
Bilirubin, mean (SD), mg/dL 1.7 (2.7) 1.2 (1.7) P < .001
Albumin, mean (SD), g/dL 3.52 (0.74) 3.71 (0.63) P < .001
Prothrombin time, mean (SD), s 14.6 (2.4) 14.1 (2.0) P < .001
INR, mean (SD) 1.18 (0.27) 1.13 (0.23) P < .001
Platelets, mean (SD), 103/μL 161.3 (95.8) 183.0 (92.5) P < .001
Creatinine, mean (SD), mg/dL 0.98 (0.71) 1.18 (0.93) P < .001
AST, mean (SD), IU/L 91.5 (84.8) 61.8 (54.2) P < .001
ALT, mean (SD), IU/L 67.0 (60.5) 50.6 (45.2) P < .001